CMS has proposed significant changes to how E&M office visits will be reimbursed starting FY2019. Based on analysis by the AMA, we noted the following highlights:
A wide range of projected impacts from -20% (Hospice) to 18% (Maxillofacial Surgery).
Family Practice and Internal Medicine show positive, albeit small, reimbursement impacts.
Urology Shows the largest overall increase in reimbursement dollars ($84.8 M).
The proposed changes have not been finalized and it will be very interesting to see what, if any, modifications to the proposed rule are included in the final rule. For more details on the proposed rule, click here.